RNA Modification Enzyme FTO Identified as Therapeutic Target in Gastrointestinal Cancers

A recent review published in Genes & Diseases highlights the enzyme FTO, which is involved in RNA modification, as a promising biomarker and therapeutic target for gastrointestinal cancers. This finding could influence future cancer treatment strategies by focusing on RNA modification pathways.

Originally published by gnews